We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Imperial Brands Plc | LSE:IMB | London | Ordinary Share | GB0004544929 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-16.00 | -0.88% | 1,811.50 | 1,813.00 | 1,813.50 | 1,844.50 | 1,812.00 | 1,835.00 | 1,216,748 | 16:35:08 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Cigarettes | 32.48B | 2.33B | 2.6392 | 6.87 | 15.99B |
Date | Subject | Author | Discuss |
---|---|---|---|
31/1/2022 15:32 | When is the next ex dividend date? I always get confused between ex dividend and record date. Thanks | 1viky | |
31/1/2022 11:23 | Oxford Cannabinoid adds Imperial Brands representative to board The company also confirmed that Julie Pomeroy will take over as chair next month Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) announced several board changes today, including the appointment of Richard Hathaway as a non-executive director with effect from 1 February. The cannabinoid pharmaceutical development company says Hathaway was nominated following an agreement between Oxford Cannabinoid and Imperial Brands Ventures Limited, a 10.87% shareholder, as its representative after the resignation of Bishrut Mukherjee in September 2021. Hathaway is corporate development director at Imperial Brands, where he is responsible for leading mergers and acquisitions as well as other strategic initiatives. He previously held a partner position at KPMG, where he was experienced in auditing and advising companies across a wide range of sectors. "We are delighted to welcome Richard Hathaway to the board as our new non-executive director, where his own extensive financial and corporate experience will be of great benefit to the company,” said chief executive John Lucas. The company also confirmed that Julie Pomeroy, currently an independent non-executive director, will step up to the role of non-executive chair with effect from 11 February. Executive chairman Neil Mahapatra will step down from his current role but remain on the board as a non-executive director, as flagged in November. spud | spud | |
28/1/2022 12:03 | spud, You'll have a lot more though ;0) | cassini | |
28/1/2022 11:39 | Think I'm in the same position as you Cassini. spud | spud | |
28/1/2022 10:32 | Yep, includes divis. My lowest buy was £14.75 I think but I bought so many nearer £19 it didn't get my average price down much. Still, glad to have them now... | cassini | |
28/1/2022 06:52 | Congratulations! Does that include divi payments? | encarter | |
28/1/2022 01:11 | chart setting up for next weeks AGM | dmore2 | |
27/1/2022 14:55 | I think I just broke even on this one... | cassini | |
27/1/2022 08:21 | Quiet. POLY looking cheap. 8% divi. DYor. | encarter | |
21/1/2022 11:51 | Top Stock Fund Merchants Bets on Dividends After 31% Gain in 2021 Merchants outperformed peers as dealmaking boosted stock picks Dividend payers set to rally on low valuations, manager says 21 January 2022, 09:23 GMT The Merchants Trust Plc is betting on big dividend payers to sustain one of the best stock fund performances in Europe. High-yielding stocks offer tantalizing valuations and have been out of favor for such a long time that they’re ripe for a rally, according to Simon Gergel, who oversees the $1.1 billion fund. Imperial Brands Plc, GlaxoSmithKline Plc and Legal & General Group Plc are all among his top holdings. spud | spud | |
19/1/2022 08:33 | I run these screens that check for high value stocks for every stock listed in London they used to be pages and pages long so you used to have to work through each stock in these large lists. Same screen now just outputs a handful of extreme dog stocks that's it no value left in the market. That's why they're buying tobacco everything else is overbought | creditcrunchies | |
17/1/2022 15:54 | And headline and first sentence of an IC Alpha screen just out: Quality sin stocks and problem solvers Our first Alpha quality screen of 2022 is topped by tobacco giant Imperial Brands (IMB), which out of all the FTSE All Share companies that doesn’t fail a test has the best combination of three-month share price momentum and operating margin. | 18bt | |
17/1/2022 15:01 | BATS raised to 3900 by Jefferies | topazfrenzy | |
17/1/2022 11:24 | Have to laugh at Jeffries pt as its a quid below the current price. Hold they say. Surely that should be sell....? spud | spud | |
17/1/2022 10:38 | JEFFERIES RAISES IMPERIAL BRANDS PRICE TARGET TO 1,616 (1,578) PENCE - 'HOLD' | philanderer | |
17/1/2022 09:59 | Great to see that the NHS will soon be doling out IMB vapes to the public! Great use of tax payers’ money. Salty. | saltaire111 | |
17/1/2022 08:58 | 'England will become the first country in the world to prescribe e-cigarettes on the NHS to help smokers quit as part of plans to increase life expectancy for the poorest.' £20 here we come! | topazfrenzy | |
17/1/2022 08:57 | 'Sajid Javid plots vaping revolution to help poor live longer' hxxps://www.thetimes | topazfrenzy | |
16/1/2022 21:12 | Spud@ #7215 - 'Fags, banks and oil - It's where it's at currently.' Ie anything lacking braggable social/eco virtue rewards investors. A parallel of 'Go woke/green, go broke' etc as they say. | jrphoenixw2 | |
15/1/2022 09:53 | Low to mid single digit dividend increases allied to debt reduction. Then BBs.spud | spud | |
14/1/2022 18:44 | Looking very bullish now. Could be £20 by summer. Salty | saltaire111 | |
14/1/2022 16:02 | Whoooohoo. How do you like me now stockpickers? | marktime1231 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions